Abstract:SDF‐1 is a ligand that plays a critical role in cancer metastases and is secreted in specialized somatic cells in the body. Its chemoattractant properties attract and induce migration of tumor cells located in other tissues in the body to the site in which SDF‐1 is secreted. This attraction and migration of tumor cells allows a new tumor to form at secondary locations within the body. Although the understanding of the function of SDF‐1 being secreted in certain regions of the body is not clear, we seek to understand the binding patterns of this ligand with its chemokine receptors CXCR4 and ACKR3 (also called CXCR7). Chemokine receptors are a subclass of G‐protein coupled receptors, which are multi‐pass transmembrane proteins with 7 TM domains. GPCR activation initiates signaling cascades within the targeted cell. Understanding which signaling pathway is favored in CXCR4 and ACKR3 can help us understand the function of SDF‐1 and the mechanism of secondary tumor formation and development. ACKR3 is considered an atypical receptor as it has been experimentally shown to not couple to Gi/o protein in many cells whereas CXCR4 can couple to either Gi/oprotein or β‐arrestin. ACKR3 strongly binds to SDF‐1 and can control the local levels of SDF‐1 available for binding to CXCR4. Both receptors can couple to β‐arrestins, which are proteins responsible for receptor internalization and potential G‐protein‐independent signaling. To understand the interplay between these two receptors in the context of their interactions with SDF‐1, Gi protein, and β‐arrestin, we have successfully generated structural models of these two receptors in apo form, as heterodimers (bound to only SDF‐1, only Gi protein, or only β‐arrestin), and as heterotrimers (bound to both SDF‐1 and Gi protein, or both SDF‐1 and β‐arrestin). These structural models have been relaxed in their physiological environment using a series of molecular dynamics (MD) simulations. Binding free energy analysis of the heterodimers is beginning to shed light on the signaling differences between the two receptors, what identifies ACKR3 as an atypical receptor, and how it sequesters excess SDF‐1 to modulate CXCR4 signaling.

β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4

Β-Arrestin2 is Critically Involved in CXCR4-mediated Chemotaxis, and This is Mediated by Its Enhancement of P38 MAPK Activation

Beta-Arrestin Differentially Regulates The Chemokine Receptor Cxcr4-Mediated Signaling And Receptor Internalization, And This Implicates Multiple Interaction Sites Between Beta-Arrestin And Cxcr4

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes

Study On Interaction Of Human Chemokine Receptor Ccr3 And Beta-Arrestin

A non-GPCR-binding partner interacts with a novel surface on β-arrestin1 to mediate GPCR signaling

Altered CXCR2 Signaling in β-Arrestin-2-Deficient Mouse Models

Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models.

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

The Chemokine Receptors CXCR1 and CXCR2 Couple to Distinct G Protein-Coupled Receptor Kinases To Mediate and Regulate Leukocyte Functions

Endosomal Chemokine Receptor Signalosomes Regulate Central Mechanisms Underlying Cell Migration

Chemokine receptor hetero-oligomers regulate monocyte chemotaxis

Identification of critical residues at the C-terminal tip of ACKR4 regulating chemokine internalization and βarrestin involvement

Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies

G protein–coupled receptor kinase phosphorylation of distal C-tail sites specifies βarrestin1-mediated signaling by chemokine receptor CXCR4

Arrestin-biased AT1R Agonism Induces Acute Catecholamine Secretion Through TRPC3 Coupling

Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias

CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems

CXCR7 Functions as a Scavenger for CXCL12 and CXCL11

The Role of SDF‐1 in Signaling Differences Between CXCR4 and Atypical ACKR3 Chemokine Receptors